PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This prospective, multicenter, nonrandomized phase-II-trial investigates in clinical practice
the differences between intensity modulated proton therapy (IMPT) and standard
intensity-modulated radiation therapy (IMRT) or volumetric-modulated arc therapy (VMAT) in
the effects on dose-volume parameters and treatment-related morbidity for women with locally
advanced cervical cancer undergoing chemoradiation.